ZIOPHARM Oncology Stock Price - ZIOP

Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Big Cap Pro
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
ZIOPHARM Oncology Inc ZIOP NASDAQ Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  -0.17 -3.87% 4.22 4.44 4.19 4.41 4.39 13:30:36
Bid Price Ask Price Spread Spread % News
4.22 4.23 0.01 0.24% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
2,573 710,673 $ 4.28 $ 3,038,418 1,899,831 1.97 - 7.25
Last Trade Time Type Quantity Stock Price Currency
13:32:32 99 $ 4.2291 USD

ZIOPHARM Oncology Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 763.95M 181.03M $ -53.12M 0.97 5.80 174.93M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

ZIOPHARM Oncology News

Loading Messages....

Latest ZIOP Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ZIOP Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week4.474.544.194.431,338,800-0.25-5.59%
1 Month4.765.154.194.631,756,119-0.54-11.34%
3 Months4.375.6053.964.801,644,547-0.15-3.43%
6 Months6.137.253.7254.891,666,569-1.91-31.16%
1 Year2.037.251.974.621,701,1392.19107.88%
3 Years5.797.881.564.471,528,544-1.57-27.12%
5 Years8.5214.931.567.002,020,439-4.30-50.47%

ZIOPHARM Oncology Description

ZIOPHARM Oncology Inc is a biotechnology company that acquires, develops, and commercializes cancer therapies. The company's preclinical and clinical pipeline focuses on treating hematological and solid tumor malignancies using cellular therapeutics. Ziopharm engages in gene therapy systems with its partner Intrexon and collaborators at the University of Texas. To fund the development of its product candidates, the company engages in contractual arrangements with licensing partners both in the United States and abroad.

Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.